Farther Finance Advisors’s Climb Bio CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.42K Hold
821
– – ﹤0.01% 4656
2026
Q2
$10.7K Buy
+821
New +$8.48K ﹤0.01% 4377

Other funds holding CLYM

Farther Finance Advisors's CLYM Position: Q3 2026 in Review

Farther Finance Advisors held its Climb Bio (CLYM) position steady in Q3 2026 at 821 shares worth $9.42K. The position accounts for ﹤0.01% of the portfolio, ranked #4656.

Farther Finance Advisors first reported a position in CLYM in Q2 2026 and has held it in 2 quarters since. The position peaked at $10.7K in Q2 2026. 3 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

  • Farther Finance Advisors held 821 shares of Climb Bio worth $9.42K as of Q3 2026.
  • Farther Finance Advisors left its Climb Bio share count unchanged in Q3 2026.
  • Climb Bio made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4656 holding.
  • Farther Finance Advisors first reported a position in Climb Bio in Q2 2026 and has held it in 2 quarters since.
  • Farther Finance Advisors's Climb Bio position peaked at $10.7K in Q2 2026.
  • 3 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.